NASDAQ:FOMX - Foamix Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$3.56 +0.04 (+1.14 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$3.56
Today's Range$3.4768 - $3.60
52-Week Range$3.21 - $7.60
Volume449,690 shs
Average Volume289,400 shs
Market Capitalization$193.24 million
P/E Ratio-2.02
Dividend YieldN/A
Beta1.73

Analyst Ratings

Foamix Pharmaceuticals (NASDAQ:FOMX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Foamix Pharmaceuticals in the last 12 months. Their average twelve-month price target is $17.6667, suggesting that the stock has a possible upside of 396.25%. The high price target for FOMX is $30.00 and the low price target for FOMX is $11.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $17.6667$17.6667$16.3333$10.00
Price Target Upside: 396.25% upside356.50% upside255.85% upside73.61% upside

Foamix Pharmaceuticals (NASDAQ:FOMX) Consensus Price Target History

Price Target History for Foamix Pharmaceuticals (NASDAQ:FOMX)

Foamix Pharmaceuticals (NASDAQ:FOMX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/4/2019HC WainwrightSet Price TargetBuy$12.00HighView Rating Details
12/12/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$11.00MediumView Rating Details
11/7/2018CowenSet Price TargetBuy$30.00N/AView Rating Details
10/11/2018Cantor FitzgeraldInitiated CoverageOverweightLowView Rating Details
12/14/2017GuggenheimReiterated RatingBuy$8.00HighView Rating Details
7/19/2017Credit Suisse GroupReiterated RatingBuy$9.00LowView Rating Details
(Data available from 2/23/2017 forward)
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Featured Article: What is Liquidity?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel